PharmaCyte Biotech, Inc. Quarterly Return On Equity in % from Q4 2011 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
PharmaCyte Biotech, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2011 to Q2 2024.
  • PharmaCyte Biotech, Inc. Return On Equity for the quarter ending July 31, 2024 was 75.1 %.
  • PharmaCyte Biotech, Inc. annual Return On Equity for 2023 was 0.42 %.
  • PharmaCyte Biotech, Inc. annual Return On Equity for 2022 was -6.19 %, a 89.5% increase from 2021.
  • PharmaCyte Biotech, Inc. annual Return On Equity for 2021 was -58.9 %, a 21.5% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 75.1 +83.9 May 1, 2024 Jul 31, 2024
Q1 2024 0.99 +6.43 Feb 1, 2024 Apr 30, 2024
Q4 2023 -2.53 +4.18 +62.3% Nov 1, 2023 Jan 31, 2024
Q3 2023 -2.27 +4.22 +65% Aug 1, 2023 Oct 31, 2023
Q2 2023 -8.82 -3.53 -66.7% May 1, 2023 Jul 31, 2023
Q1 2023 -5.44 +0.63 +10.4% Feb 1, 2023 Apr 30, 2023
Q4 2022 -6.71 +1 +13% Nov 1, 2022 Jan 31, 2023
Q3 2022 -6.49 +6.78 +51.1% Aug 1, 2022 Oct 31, 2022
Q2 2022 -5.29 +46.9 +89.9% May 1, 2022 Jul 31, 2022
Q1 2022 -6.08 +43.2 +87.7% Feb 1, 2022 Apr 30, 2022
Q4 2021 -7.71 +41.4 +84.3% Nov 1, 2021 Jan 31, 2022
Q3 2021 -13.3 +44.6 +77% Aug 1, 2021 Oct 31, 2021
Q2 2021 -52.2 +18.6 +26.3% May 1, 2021 Jul 31, 2021
Q1 2021 -49.3 +31.5 +39% Feb 1, 2021 Apr 30, 2021
Q4 2020 -49.1 +40.2 +45% Nov 1, 2020 Jan 31, 2021
Q3 2020 -57.8 +22.7 +28.2% Aug 1, 2020 Oct 31, 2020
Q2 2020 -70.9 +5.75 +7.51% May 1, 2020 Jul 31, 2020
Q1 2020 -80.8 -6.89 -9.32% Feb 1, 2020 Apr 30, 2020
Q4 2019 -89.3 -14.9 -20.1% Nov 1, 2019 Jan 31, 2020
Q3 2019 -80.6 +15.6 +16.2% Aug 1, 2019 Oct 31, 2019
Q2 2019 -76.6 +24.5 +24.2% May 1, 2019 Jul 31, 2019
Q1 2019 -73.9 +25 +25.3% Feb 1, 2019 Apr 30, 2019
Q4 2018 -74.3 +15.1 +16.9% Nov 1, 2018 Jan 31, 2019
Q3 2018 -96.1 -19.8 -26% Aug 1, 2018 Oct 31, 2018
Q2 2018 -101 -33.2 -49% May 1, 2018 Jul 31, 2018
Q1 2018 -98.9 -36.5 -58.5% Feb 1, 2018 Apr 30, 2018
Q4 2017 -89.4 -23.8 -36.3% Nov 1, 2017 Jan 31, 2018
Q3 2017 -76.3 -2.92 -3.98% Aug 1, 2017 Oct 31, 2017
Q2 2017 -67.9 +13.6 +16.6% May 1, 2017 Jul 31, 2017
Q1 2017 -62.4 +23.6 +27.5% Feb 1, 2017 Apr 30, 2017
Q4 2016 -65.6 +56.2 +46.2% Nov 1, 2016 Jan 31, 2017
Q3 2016 -73.4 +46.7 +38.9% Aug 1, 2016 Oct 31, 2016
Q2 2016 -81.4 +58.3 +41.7% May 1, 2016 Jul 31, 2016
Q1 2016 -86.1 +54.6 +38.8% Feb 1, 2016 Apr 30, 2016
Q4 2015 -122 +183 +60% Nov 1, 2015 Jan 31, 2016
Q3 2015 -120 +182 +60.2% Aug 1, 2015 Oct 31, 2015
Q2 2015 -140 +239 +63.1% May 1, 2015 Jul 31, 2015
Q1 2015 -141 +415 +74.7% Feb 1, 2015 Apr 30, 2015
Q4 2014 -304 +179 +37.1% Nov 1, 2014 Jan 31, 2015
Q3 2014 -302 +1.93K +86.5% Aug 1, 2014 Oct 31, 2014
Q2 2014 -378 -1K -161% May 1, 2014 Jul 31, 2014
Q1 2014 -555 -636 -791% Feb 1, 2014 Apr 30, 2014
Q4 2013 -484 -565 -696% Nov 1, 2013 Jan 31, 2014
Q3 2013 -2.24K -2.31K -3099% Aug 1, 2013 Oct 31, 2013
Q2 2013 625 +550 +740% May 1, 2013 Jul 31, 2013
Q1 2013 80.3 -1.28 -1.57% Feb 1, 2013 Apr 30, 2013
Q4 2012 81.3 -20.8 -20.3% Nov 1, 2012 Jan 31, 2013
Q3 2012 74.6 Aug 1, 2012 Oct 31, 2012
Q2 2012 74.3 May 1, 2012 Jul 31, 2012
Q1 2012 81.6 Feb 1, 2012 Apr 30, 2012
Q4 2011 102 Nov 1, 2011 Jan 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.